Direxion Daily S&P Biotec... (LABD)
AMEX: LABD
· Real-Time Price · USD
38.80
-1.64 (-4.06%)
At close: Oct 01, 2025, 10:56 AM
-4.06% (1D)
| Bid | 38.68 |
| Market Cap | 594.75M |
| AUM | 6.96M |
| NAV | 4.33 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Shares Out | 15.33M |
| Inception Date | May 28, 2015 |
| Ask | 38.83 |
| Volume | 1,146,633 |
| Open | 40.68 |
| Previous Close | 40.44 |
| Day's Range | 38.44 - 40.69 |
| 52-Week Range | 38.44 - 160.50 |
| Holdings | 11 |
| Expense Ratio | 0.97% |
About LABD
The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Asset Class Equity
Ticker Symbol LABD
Inception Date May 28, 2015
Provider Direxion
Website Fund Home Page
Exchange AMEX
Top 10 Holdings 25.61% of assets
| Name | Symbol | Weight |
|---|---|---|
| Dreyfus Govt Cash Ma... | 10.06% | |
| Goldman Finl Sq Trsr... | 8.86% | |
| Goldman Sachs Fin Go... | 4.32% | |
| Dreyfus Trsry Securi... | 2.37% |
Dividends Dividend Yield 0.54%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Sep 23, 2025 | $0.0260 | Sep 30, 2025 |
| Jun 24, 2025 | $0.0370 | Jul 1, 2025 |
| Mar 25, 2025 | $0.0546 | Apr 1, 2025 |
| Dec 23, 2024 | $0.1264 | Dec 31, 2024 |
| Sep 24, 2024 | $0.0577 | Oct 1, 2024 |
